tradingkey.logo

Sharps Technology Inc

STSS
查看详细走势图
2.220USD
+0.210+10.45%
收盘 12/19, 16:00美东报价延迟15分钟
61.33M总市值
亏损市盈率 TTM

Sharps Technology Inc

2.220
+0.210+10.45%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+10.45%

5天

-17.16%

1月

-21.55%

6月

-57.31%

今年开始到现在

-99.64%

1年

-99.61%

查看详细走势图

TradingKey Sharps Technology Inc股票评分

单位: USD 更新时间: 2025-12-19

操作建议

Sharps Technology Inc当前公司基本面数据相对健康,增长潜力较大。当前估值合理,在医疗设备与耗材行业排名148/208位。机构持股占比非常低,近一月多位分析师给出公司评级为买入。最高目标价22.00。中期看,股价处于下降通道。近一个月,市场表现非常差,基本面和技术面综合得分也较低。目前股价在压力位和支撑位之间,可以做区间波段操作。

Sharps Technology Inc评分

相关信息

行业排名
148 / 208
全市场排名
396 / 4582
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 1 位分析师
买入
评级
22.000
目标均价
+752.71%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Sharps Technology Inc亮点

亮点风险
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
利润高增长
公司净利润处于行业前列,最新年度总收入0.00美元
估值高估
公司最新PE估值-0.00,处于3年历史高位
机构减仓
最新机构持股24.05K股,环比减少67.21%
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值17.85K

Sharps Technology Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Sharps Technology Inc简介

Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
公司代码STSS
公司Sharps Technology Inc
CEOMr. Robert M. Hayes
网址https://sharpstechnology.com/

常见问题

Sharps Technology Inc(STSS)的当前股价是多少?

Sharps Technology Inc(STSS)的当前股价是 2.220。

Sharps Technology Inc的股票代码是什么?

Sharps Technology Inc的股票代码是STSS。

Sharps Technology Inc股票的52周最高点是多少?

Sharps Technology Inc股票的52周最高点是690.000。

Sharps Technology Inc股票的52周最低点是多少?

Sharps Technology Inc股票的52周最低点是2.210。

Sharps Technology Inc的市值是多少?

Sharps Technology Inc的市值是61.33M。

Sharps Technology Inc的净利润是多少?

Sharps Technology Inc的净利润为-9.30M。

现在Sharps Technology Inc(STSS)的股票是买入、持有还是卖出?

根据分析师评级,Sharps Technology Inc(STSS)的总体评级为买入,目标价格为22.000。

Sharps Technology Inc(STSS)股票的每股收益(EPS TTM)是多少

Sharps Technology Inc(STSS)股票的每股收益(EPS TTM)是-873.265。
KeyAI